Pancreatic Cancer Research

ResearcherSouth China University of TechnologyActive in the last 2 years

Qihui Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-4289-2771; OpenAlex author ID A5078431747. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 4

  1. Oncogenic Peptide Encoded by Noncoding RNA of FOXM1 Promotes Pancreatic Cancer Malignancy Through PI3K/AKT Signaling. Co-author DOI 10.1002/mc.70051↗
  2. OSBPL3-driven sterol metabolic reprogramming promotes oncogenic signaling and therapeutic resistance in pancreatic cancer. Co-author DOI 10.7150/thno.113637↗
  3. OSBPL3 modulates the immunosuppressive microenvironment and predicts therapeutic outcomes in pancreatic cancer. Co-author DOI 10.1186/s13062-025-00596-0↗
  4. Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-23-1143↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keping Xie · 4 shared papers, 2023–2026 · strength 1.01
  2. Xiaojia Li · 2 shared papers, 2025–2026 · strength 0.53
  3. Xinyan Huang · 1 shared paper, 2026 · strength 0.29
  4. Jia Liu · 1 shared paper, 2025 · strength 0.25
  5. Xiangyu Kong · 1 shared paper, 2023 · strength 0.17
  6. Tiansuo Zhao · 1 shared paper, 2023 · strength 0.17
  7. Fanyang Kong · 1 shared paper, 2023 · strength 0.17
  8. Shaofei Chang · 1 shared paper, 2023 · strength 0.17
  9. Jihui Hao · 1 shared paper, 2023 · strength 0.17
  10. Fang Wei · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.